Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (251-260 of 339) with videos related to

Pageof 34
Sort By:
Haematologica|April 6, 2023
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research NetworkChristina M Termini, Anna Moseley, Megan Othus, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
Blood|May 7, 2014
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortalityMohamed L Sorror, Paul J Martin, Rainer F Storb, et al.
British Journal of Haematology|February 18, 2014
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapySteven E Coutre, Megan Othus, Bayard Powell, et al.
Blood|May 17, 2003
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysisAjay K Gopal, Theodore A Gooley, David G Maloney, et al.
Blood|July 12, 2003
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G Maloney, Arthur J Molina, Firoozeh Sahebi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2007
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997Michael R Grever, David M Lucas, Gordon W Dewald, et al.
Blood|November 13, 2008
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesMarco Mielcarek, Barry E Storer, Michael Boeckh, et al.
Blood Advances|October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 studyIbrahim Aldoss, Jun Yin, Anna Wall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndromeRaya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
Pageof 34

Showing results (251-260 of 339) with videos related to

Sort By:
Pageof 34
Haematologica|April 6, 2023
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research NetworkChristina M Termini, Anna Moseley, Megan Othus, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
Blood|May 7, 2014
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortalityMohamed L Sorror, Paul J Martin, Rainer F Storb, et al.
British Journal of Haematology|February 18, 2014
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapySteven E Coutre, Megan Othus, Bayard Powell, et al.
Blood|May 17, 2003
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysisAjay K Gopal, Theodore A Gooley, David G Maloney, et al.
Blood|July 12, 2003
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G Maloney, Arthur J Molina, Firoozeh Sahebi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2007
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997Michael R Grever, David M Lucas, Gordon W Dewald, et al.
Blood|November 13, 2008
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesMarco Mielcarek, Barry E Storer, Michael Boeckh, et al.
Blood Advances|October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 studyIbrahim Aldoss, Jun Yin, Anna Wall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndromeRaya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
Pageof 34